CalciMedica Inc.

NASDAQ: CALC · Real-Time Price · USD
2.87
0.26 (9.96%)
At close: Aug 15, 2025, 3:59 PM
2.89
0.87%
After-hours: Aug 15, 2025, 07:11 PM EDT

CalciMedica Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
60K 60K 60K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
60K 75K 75K 64K 61K 60K 58K 39K 212K 415K 615K 751K 702K 485K 272K 136K n/a n/a
Gross Profit
n/a -15K -15K -64K -61K -60K -58K -39K -212K -415K -615K -751K -702K -485K -272K -136K n/a n/a
Operating Income
-25.03M -24.93M -24.2M -22.35M -21.45M -21.5M -38.08M -41.47M -46.62M -48.34M -36.18M -37.17M -35.2M -34.64M -35.95M -36.42M -35.23M -33.52M
Interest Income
220K n/a n/a n/a n/a n/a n/a 309K 480K 540K 575K 292K 149K 122K 126K 123K 98K 74K
Pretax Income
-20.87M -18.87M -13.7M -13.59M -12.59M -14.94M -34.36M -37.61M -42.81M -44.74M -35.6M -36.88M -35.05M -34.52M -35.82M -36.3M -33.02M -31.19M
Net Income
-20.87M -18.87M -13.7M -13.59M -12.59M -14.94M -34.36M -37.61M -42.81M -44.74M -35.6M -36.88M -35.05M -34.52M -35.82M -36.3M -33.02M -31.19M
Selling & General & Admin
9.37M 9.18M 9.73M 8.92M 8.79M 9.19M 22.22M 27.11M 29.35M 30.83M 19.1M 17.1M 16.8M 16.13M 17.04M 16.3M 14.37M 12.2M
Research & Development
15.65M 15.76M 14.48M 13.43M 12.65M 12.31M 15.86M 13.83M 14.3M 14.55M 14.11M 17.63M 18.4M 18.51M 18.9M 20.12M 20.86M 21.32M
Other Expenses
n/a n/a n/a n/a n/a n/a -116K -116K -165K -194K -78K -78K -29K n/a n/a n/a n/a n/a
Operating Expenses
25.03M 24.93M 24.2M 22.35M 21.45M 21.5M 38.08M 40.94M 43.66M 45.37M 33.22M 34.73M 35.2M 34.64M 35.95M 36.42M 35.23M 33.52M
Interest Expense
-123K -447K n/a n/a n/a n/a n/a n/a 171K 231K 266K 292K 149K 122K 126K 123K 98K 74K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
25.03M 24.93M 24.2M 22.35M 21.45M 21.5M 38.08M 40.94M 43.66M 45.37M 33.22M 34.73M 35.2M 34.64M 35.95M 36.42M 35.23M 33.52M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a 2.26M 2.14M 2.05M 2.05M -216K -91K n/a n/a n/a -9K
Shares Outstanding (Basic)
15B 14.12M 12.76M 11.13M 11.13M 9.75M 5.74M 5.67M 5.66M 820K 1.54M 1.53M 1.53M 1.53M 1.52M 1.52M 1.51M 1.5M
Shares Outstanding (Diluted)
15B 14.12M 12.76M 11.13M 11.13M 10.05M 5.74M 5.67M 5.66M 820K 1.54M 1.53M 1.53M 1.53M 1.52M 1.52M 1.51M 1.5M
EPS (Basic)
-1.59 -1.55 -1.18 -1.57 -1.88 -2.63 -26.16 -30.23 -35.81 -40.07 -23.16 -24.06 -22.92 -22.65 -23.67 -24.09 -42.27 -41.46
EPS (Diluted)
-1.59 -1.55 -1.18 -1.57 -1.88 -2.63 -26.16 -30.23 -35.81 -40.07 -23.16 -24.06 -22.92 -22.65 -23.67 -24.09 -42.27 -41.46
EBITDA
-23.08M -22.99M -22.25M -18.47M -17.57M -17.61M -34.19M -40.37M -40.57M -42.31M -30.04M -31.95M -34.81M -34.12M -34.08M -34.58M -33.42M -31.75M
EBIT
-20.22M -21.12M -22.29M -18.52M -17.62M -17.67M -34.25M -40.94M -39.4M -36.4M -18.27M -19.79M -24.52M -28.67M -34.59M -35.07M -33.87M -32.17M
Depreciation & Amortization
44K 58K 58K 63K 60K 60K 58K 1.09M 1.27M 1.47M 1.67M 751K 702K 614K 519K 494K 454K 420K